机译:延迟折现和辅助内分泌疗法遵守激素受体阳性乳腺癌
Virginia Tech, Dept Internal Med, Carilion Sch Med, Blacksburg, VA USA;
Fralin Biomed Res Inst VTC, Ctr Transformat Res Hlth Behav, 1 Riverside Circle, Roanoke, VA 24016 USA;
Ohio State Univ, Stefanie Spielman Comprehens Breast Ctr, Columbus, OH 43210 USA;
therapy, endocrine; Medication Adherence; Delay DiscountingPatient ComplianceBreast CancerElectronic funds transferMucilages, AdhesiveHormone Receptordirect digital synthesisSurvivorsMedication Nonadherence;
机译:风险分类在淋巴结阴性乳腺癌中的长期预后影响–比较Adjuvant!,St。Gallen和在前瞻性随机Node-Negative-Breast-Cancer-3试验(NNBC-3)中使用的新型风险算法
机译:风险分类在淋巴结阴性乳腺癌中的长期预后影响–比较Adjuvant!,St。Gallen和在前瞻性随机Node-Negative-Breast-Cancer-3试验(NNBC-3)中使用的新型风险算法
机译:乳癌干细胞と分子标的治疗Breast cancer stem cell and molecular targeted therapy
机译:CDO1 promoter methylation is a Biomarker for Outcome prediction of anthracycline Treated, Estrogen Receptor-positive, Lymph Node-positive Breast Cancer patients